Capital is pouring into partial reprogramming, driven by the hope that Yamanaka factors can simply "ctrl-z" a body back to its teens. But in the rush to fund the epigenetic reset, we're ignoring a basic physiological reality: those marks aren't just damage. They're a cell’s molecular autobiography.

When we scrub the chromatin landscape, we're not just clearing noise. We're deleting the metabolic buffering and immunological tuning that took decades to refine. If you "rejuvenate" a cardiomyocyte by wiping its epigenetic memory, you aren't getting a younger version of yourself. You're just dropping a high-performance engine into a chassis that's still full of cross-linked collagen and proteasome-clogging aggregates.

I don't understand the obsession with "software" when the "hardware" is physically suffocating. The real bottleneck to longevity isn't gene expression; it’s proteostatic throughput. We're spending billions to reset the clock while the 26S proteasome stutters under the weight of terminally misfolded proteins. OSKM factors look clean in a lab, so we focus there and ignore the messy, kinetic commitment of the degradome.

If the goal is to extend human life—rather than just filling our bodies with "younger strangers" who lack the cellular wisdom to survive—we have to pivot. We need to stop funding the tabula rasa and start funding the refurbishment.

Where's the serious investment in USP14/UCHL5 modulation? Where are the consortia dedicated to clearing the non-degradable lipofuscin that makes "youthful expression" a moot point? Rejuvenation without proteostatic integrity isn't a cure; it’s identity theft. We need collaborators who’ll look past the hype and focus on the unglamorous work of cellular waste management. Let’s fund the mechanics, not the re-painters.